Betongsentrum AS is offering an easier online solution for planning and ordering concrete for your project. Our digital platform makes concrete deliveries more efficient, safer and more environmentally friendly along with giving all project participants a visual overview of the progress and their own responsibilities. This ensures quality in every link, satisfied customers and a better end result.

70% of all processes of change fail. We believe that is because it lacks the practical implementation, and thats were we come in. We create engaging games based upon the businesses wanted culture and goals. We at Someday are tired of all the talk from sustainability to remote work to employee engagement and there are so little effort. We wanted to do something about that and we gathered the experience from our times as CEOs, trainers and UX and came up with Someday Business

At Vitaloop, we are working on giving you clean water everywhere. We make it whole again, removing substances and pollution left by our actions. In a rapidly changing world, Vitaloop will be insurance, proven access to the one thing no one can exist without – clean, fresh, and healthy water. Our go-to-market product is called VITALOOP ORIGIN and is a ground-breaking, patented, high-tech water cleaning bottle that can remove almost everything harmful, manufactured and caused by climate change. It's your own mobile water filtration station using the revolutionary nanomaterial Graphene. It runs by a powerful pump and a rechargeable battery that will clean 450 ml of water in 60 seconds. Vitaloop Origin provides true independence wherever and whenever. VITALOOP- Water restored.

Otivio’s main product, FlowOx™, is addressing chronic wounds with focus on peripheral arterial disease (PAD), which is a serious condition leading to pain, chronic wounds and in many cases amputation and mortality. The patient population is very large and increasing. There are limited adequate treatment options offered to the patients aside from surgical interventions. FlowOx™ is a non-invasive product intended for home use. Long-term patient testing in more than 50 patients documents increased blood flow, reduced pain and wound healing. FlowOx™ is CE marked. In fourth quarter 2017 had its commercial break-through through sales of FlowOx to public customers.

RESPINOR is a privately-owned medical device company, founded in Oslo, 2015. We have developed an objective measure of breathing for critically ill patients within intensive care. The technology provides precise, continuous and real-time information of diaphragm function, our main breathing muscle, to increase the quality of care and reducing costs. RESPINOR’s technology is the winner of Horizon 2020 both in phase I and II. We are addressing an unmet medical need because every breath counts.

Nordea er en av Nordens største totalbanker Nordens største bank gjennomfører et helt unikt startup-stunt. Se ledige stillinger for mer informasjon. Med mer enn 10 millioner kunder og 30.000 medarbeidere er vi en av de ti største totalbankene i Europa. Vi har en omfattende kompetanse på et vidt spekter av produkter, tjenester og løsninger innenfor bank, kapitalforvaltning og forsikring. Nordea er en av få europeiske banker med AA-rating.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

BRIK as is a company specialising in new web technology, pedagogy and professional dissemination of knowledge. The team has extensive experience in the dissemination of knowledge with new web technologies and video. Our investors and partners are Innovation Norway, the Norwegian Research Council and several customer partners. The budget for the initial development phase (2013 - ) has been 12 MNOK. Now we are looking for partners for the next stage, where we will commercialize and increase sales.

CYBERSECURITY FOR INDUSTRIAL NETWORKS AND CONTROL SYSTEMS Secure-NOK® is a technology company providing cybersecurity solutions for monitoring industrial networks (OT), and for detecting vulnerable areas. The company has vast experience and recognized technology, and has participated in several research projects with outstanding results. The technology (SNOK) can detect any abnormal event in a network and prevent important infrastructure from experiencing downtime due to malicious attack. Today, most industries are digitized, and thus more exposed to attacks from the outside. With technology from Secure-NOK, such attacks will be detected early, and thus avoid damage and downtime. Secure-NOK has developed patented sensors which are installed in a OT network, and which capture and report any abnormal traffic. The company has sensors for both networks, end-stations and PLC systems.

Pixotope Technologies is an international, award-winning technology and service company headquartered in Norway. Our flagship product Pixotope® is the world’s leading mixed reality solution for media production that allows media producers and content creators to produce exciting mixed reality content for television, online streaming, and film. Our product and services have been used in some of the largest live productions made in the last few years, such as the Superbowl, League of Legends Championship broadcasts, Euro-vision, and The Weather Channels mixed reality experiences. A selection of these productions can be viewed on our website: https://www.pixotope.com/customers We are a global company with headquarters in Oslo and branch offices in Los Angeles, London, Madrid, and Zagreb. Our customers are from every corner of the world.

At BARK™DNA we believe that a confident appearance empowers us to own our presence. We want to be the obvious choice for the man who wants to put his best forward. We are the next-generation skincare brand aiming to redefine skincare for men. We confront stereotypes and introduce hybrid skincare solutions that instantly camouflages issues while at the same time offering the appropriate dermatological treatment for men’s unique skin. At BARK™DNA we are chasing a window of opportunity. Non have darted taking the risk to challenge status quo in the conservative men’s cosmetic industry which are struggling with a low degree of innovation. We won’t have that! Men deserve skincare that is formulated for their needs. And they deserve solutions that work.

By digitalize the consumers wardrobe, we provide the consumers with a structured and categorized view of their wardrobe. The user can organize their clothing into digital, customized drawers, put together new outfits, schedule outfits forward, get statistics on their style and spending and see eachothers wardrobes, so it will be easier to share and borrow clothes from eachother. We're launching start november 2022 and already pre-launch we have over 5300K sign ups and above 32K followers on Tiktok.

Newday Coffee is a new danish coffee startup that focus on creating the perfect cup of coffee with quality, convenience and sustainability as our core focus. Our main product is single-serve coffeebags, that insures a much longer lifespan on the coffee, due to our speciel nitrogen packaging. Coffeebags gives you the same taste and quality you would find when brewing frenchpress or filtercoffee. The difference lies in the convenience and expiry date of the coffee. Coffebags makes it much easier to brew a quality cup of coffee, and when you only brew one cup at a time, you don't need to open an entire 'ordinary' coffeebag, which loses it's taste after a few weeks. We started Newday Coffee to provide a product we ourself needed and wanted. Our need was that we always wanted to ensure that we had a fantastic cup of coffee close.

Bad Forecasts Kill Businesses: Working capital cost, natural resource waste, overproduction, lost sales... MIR is the Sherlock Holmes for your business. We identify the most important influence factors out of billions of market data for maximum profit, minimum waste, thanks to the best forecasting accuracy.

syntheticAIdata helps businesses across various industries overcome the challenge of acquiring high-quality data for training their vision AI models. Our solution generates synthetic data that empowers clients to easily create diverse datasets at scale. By leveraging syntheticAIdata, clients can achieve many benefits, including significant cost reduction, privacy, and regulatory compliance, and bring their AI products to market faster. In today's competitive market, the accuracy of AI models plays a crucial role. Leveraging synthetic data can enhance the accuracy of these models, making it a crucial factor to consider for businesses looking to stay ahead of the competition. Synthetic data is one of the most promising techniques on the rise in modern deep learning, especially computer vision. syntheticAIdata is supported by Microsoft for Startups and part of NVIDIA Inception program.